Eric Borges
25Patents
7h-index
33Co-inventors
65Inventor score
Filing activity: Dec 15, 2003 → Jun 1, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9150664B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 54 | Active |
| US9340621B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 51 | Active |
| US7498416B2 | Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof | Chemistry; Metallurgy | 43 | Expired |
| US7705130B2 | Antibodies directed to HER-3 and uses thereof | Chemistry; Metallurgy | 40 | Active |
| US9598500B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 17 | Active |
| US8318159B2 | Anti-IGF antibodies | Emerging Cross-Sectional Technologies | 10 | Active |
| US8828385B2 | Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US8771695B2 | Antibodies directed to HER-3 and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US9079958B2 | CD33 binding agents | Chemistry; Metallurgy | 5 | Active |
| US10752694B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 5 | Active |
| US10766969B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 4 | Active |
| US9550833B2 | CD33 binding agents | Chemistry; Metallurgy | 4 | Active |
| US10179810B2 | Anti-IGF antibodies | Emerging Cross-Sectional Technologies | 1 | Active |
| US9078879B2 | Anti CD37 antibodies | Chemistry; Metallurgy | 1 | Active |
| US10202451B2 | CD33 binding agents | Chemistry; Metallurgy | 1 | Active |
| US9249230B2 | Antibodies directed to HER-3 and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12281175B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 0 | Active |
| US11999800B2 | Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer | General | 0 | Revoked |
| US11267900B2 | Antibodies directed to HER-3 and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8828382B2 | Heparin-binding epidermal growth factor-like growth factor binding proteins | Chemistry; Metallurgy | 0 | Active |
| US12146000B2 | Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US12281176B2 | Binding molecules for BCMA and CD3 | Chemistry; Metallurgy | 0 | Active |
| US9932399B2 | Anti CD37 antibodies | Chemistry; Metallurgy | 0 | Active |
| US11299538B2 | Anti-IGF antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US10100124B2 | Antibodies directed to HER-3 and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.